logo
  

Domino's Pizza Q3 Total System Sales Down 8.3%

Domino's Pizza Group plc (DOM.L,DPZ) reported that its third quarter total system sales declined 8.3% to 344.7 million pounds from prior year. It will roll out on Just Eat platform in the UK and Ireland following successful trial. The company announced a further 20 million pounds share buyback with immediate effect.

Like-for-like system sales across UK & Ireland for the third quarter declined by 9.3%, excluding split stores, or by 10.2% including splits, again driven by the increase in VAT.

In the first six weeks of fourth quarter like-for-like system sales excluding split stores and VAT have increased by 10.4% driven by franchise partners' focus on service, focus on digital, strong national value campaigns, collections growth and the initial incremental benefit of being on the Just Eat platform.

For fiscal year 2022, the company expects underlying EBITDA to be in the range of 125 million pounds to 135 million pounds, in line with current market expectations. Excluding the impact of the additional investment project costs outlined above, underlying earnings per share is also expected to be in line with current market expectations.

Domino's said it will roll out on Just Eat platform in the UK and Ireland following very successful trial.

As at 10 November 2022 1,061 stores are now live, and Domino's expects the roll out to be complete by the end of fiscal year 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT